NASDAQ · Financial Statements
Baudax Bio, Inc. (BXRX) Financial Statements
$0.02
NASDAQ: BXRX
Overview Financials Dividend Baudax Bio, Inc. most recently reported annual revenue of $1.0M, a net loss of $59.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $0 $0 $0 $1.0M $1.0M Operating Profit $-74.0M $-33.0M $-75.0M $-19.0M $-36.0M Net Profit $-74.0M $-18.0M $-76.0M $-20.0M $-59.0M EPS $-11361.35 $-2695.87 $-5715.36 $-361.16 $-177.30 Op Margin — — -15169.6% -1759.8% -2816.6%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $35.0M $54.0M $69.0M $53.0M $10.0M Total Liabilities $103.0M $71.0M $84.0M $40.0M $34.0M Cash $0 $18.0M $30.0M $16.0M $5.0M Borrowings $0 $1.0M $10.0M $9.0M $7.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-60.0M $-50.0M $-44.0M $-49.0M $-28.0M Investing Cash Flow $-7.0M $-3.0M $-1.0M $0 $0 Financing Cash Flow $63.0M $69.0M $57.0M $35.0M $17.0M Net Cash Flow $0 $18.0M $13.0M $-14.0M $-11.0M Free Cash Flow $-63.0M $-52.0M $-45.0M $-49.0M $-28.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.05 FCF Yield — Quick Ratio 0.30 Interest Coverage -1.70 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .